Clinical Trial Update: Multinational Phase II Trial to Compare Safety and Efficacy of SIRT (Y-90 Resin Microspheres) Followed by Atezolizumab Plus Bevacizumab, vs SIRT (SIRT-Y90) Followed by Placebo in Locally Advanced HCC Patients [Phase 2]

View source ↗

Summary

Phase II multinational trial comparing safety and efficacy of SIRT (Y-90 resin microspheres) followed by atezolizumab plus bevacizumab versus SIRT followed by p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Atezolizumab (atezolizumab)
• Bevacizumab (bevacizumab)
• SIR-Spheres Y-90 resin microspheres (yttrium-90 resin microspheres)

Snippet

Sponsor: National Cancer Centre, Singapore | Conditions: Locally Advanced Hepatocellular Carcinoma | Phase 2 | Status: RECRUITING